Skip to main content
RecallRadar
FDAClass III

Buprenorphine Sublingual Tablets (C-III), 2 mg, 30 Tablets (3x10), Rx only, Distributed b… Recalled: Labeling: Label Mix-up

Buprenorphine Sublingual Tablets (C-III), 2 mg, 30 Tablets… was recalled on August 19, 2026 in cooperation with the U.S. Food and Drug Administration because labeling: Label Mix-up.

Is my unit affected?

Buprenorphine Sublingual Tablets (C-III), 2 mg, 30 Tablets (3x10), Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton NDC#: 60687-481-21, (Individual Dose NDC: 60687-481-11).

Model, lot & date codes to check

Lot # 1030023, Exp Date: 06/30/2027.

Units affected: 10,953 cartons.

Where it was sold: US Nationwide.

Compare the codes above against the label on your product — usually on the bottom, the back panel, or the packaging. If your unit isn't listed, it is not part of this recall.

What's the hazard?

Labeling: Label Mix-up

Class III means the product is unlikely to cause a health problem, but it violates FDA labeling or manufacturing rules.

Your remedy & how to claim it

Stop using the product. Return it to the place of purchase for a refund, or dispose of it. Contact the recalling firm with questions.

Contact: Recalling firm: American Health Packaging

Not sure what you're entitled to? Read our guide: what to do if your product is recalled.

Official recall notice

Always confirm details on the official notice from the U.S. Food and Drug Administration before acting.

View official notice →

Get recall alerts

Be the first to know when products like this are recalled. Free weekly digest, unsubscribe anytime.

Double opt-in: we only email you after you confirm. No spam, ever.